Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

CVD in CKD Patients: Heart–Kidney Team-Based Approach

Published:

07 December 2021

Citation:

European Cardiology Review 2021;16:e48.

Women and Diabetes: Preventing Heart Disease in a New Era of Therapies

Published:

21 October 2021

Citation:

European Cardiology Review 2021;16:e40.

The Future of Telemedicine in the Management of Heart Failure Patients

Published:

28 May 2021

Citation:

Cardiac Failure Review 2021;7:e11.

Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis

Citation:

European Cardiology Review 2020;15:e37.